Concepedia

Publication | Closed Access

Hepatic volumetry to predict adverse events in percutaneous ablation of hepatocellular carcinoma.

18

Citations

0

References

2002

Year

Yujin Hoshida, Yasushi Shiratori, Yukihiro Koike, Shuntaro Obi, Keisuke Hamamura, Takuma Teratani, Shuichiro Shiina, Masao Omata
PubMed

Abstract

Measurement of liver volume and parenchymal ablation rate are useful to predict the presence of percutaneous ablation-related adverse events.